GlassScriptPhysician profile
Nathaniel J Holmes
NPI 1801868187
$3,687.16
in general payments reported to CMS, 2019-2025
19 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,658 · 2024: $1,670 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,255 · Food and Beverage: $1,207 · Education: $210 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,254.80 |
| Food and Beverage | $1,206.52 |
| Education | $209.59 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,881.48 | 2023-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $180.20 | 2024 | Interstim |
| Kerecis Limited | $153.53 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Baxter Healthcare | $91.04 | 2025 | Floseal, Perclot |
| Olympus America INC. | $58.64 | 2023-2025 | Olympus, Olympus |
| Laborie Medical Technologies Corp. | $35.61 | 2023 | |
| Tela Bio, INC. | $35.23 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Vertex Pharmaceuticals Incorporated | $32.01 | 2024-2025 | |
| Sanara Medtech INC. | $26.65 | 2025 | Biasurge |
| Mimedx Group, INC. | $26.02 | 2025 | |
| Davol INC. | $21.49 | 2025 | Phasix Mesh |
| Braintree Laboratories, INC. | $20.85 | 2023 | Sutab |
| Mesh Suture INC | $19.49 | 2025 | |
| Solventum Corporation | $19.02 | 2024 | V.A.C.Ulta, Bair Hugger, V.A.C.Instill |
| Teleflex LLC | $18.81 | 2025 | Titan Sgs Bailout Chuck |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.53 | 2025 | Zepbound |
| Pacira Pharmaceuticals Incorporated | $17.45 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $16.11 | 2024 | Localizer |
| Integra Lifesciences Corporation | $16.00 | 2024 | Integra, Omnigraft, Surgimend |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.